Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1996
12/03/1996US5580558 Delivery of gene products via mesangial cells
12/03/1996US5580552 7-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
12/03/1996CA2036997C Leu3a binding peptides
11/1996
11/28/1996WO1996037626A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
11/28/1996WO1996037624A1 A method for producing influenza hemagglutinin multivalent vaccines
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037222A1 Vaccine composition containing polyribosylribitol phosphate and method for making same
11/28/1996WO1996037216A1 Method of administration of igf-i
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2218018A1 Method of administration of igf-i
11/27/1996EP0743951A1 Substituted lactose derivatives as cell adhesion inhibitors
11/27/1996EP0743939A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
11/27/1996EP0743856A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136777A Immunomodulating compositions from bile
11/27/1996CN1136775A Treatment of allergic disorders with terfenadine carboxylate
11/27/1996CN1033365C Preparing method for lipides composition containing scutellaria compound
11/26/1996US5578707 Soluble interferon-gamma receptor fragment
11/26/1996US5578634 1H-indole-3-acetic acid hydrazide sPLA2 inhibitors
11/26/1996US5578616 Antiinflammatory agents, antiallergens, treatment for gastrointestinal and cardiovascular disorders
11/26/1996US5578610 Piperidine derivatives
11/26/1996US5578589 Method for suppressing an immunoresponse with an estradiol derivative-chlorambucil conjugate
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036625A1 Phenyl dihydrobenzofuranes
11/21/1996WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996WO1996036608A1 α,β-UNSATURATED KETONE DERIVATIVES
11/21/1996WO1996036366A1 Gene therapy for effector cell regulation
11/21/1996WO1996036359A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
11/21/1996WO1996036355A1 Leptospira membrane proteins
11/21/1996WO1996036324A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996WO1996030042A3 Methods of treating inflammation and compositions therefor
11/21/1996CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996CA2221357A1 Phenyl dihydrobenzofuranes
11/21/1996CA2221350A1 Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
11/21/1996CA2221305A1 Gene therapy for effector cell regulation
11/21/1996CA2220687A1 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996CA2220674A1 Leptospira membrane proteins
11/21/1996CA2219487A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
11/21/1996CA2218548A1 Xanthines and their therapeutic use
11/20/1996EP0743300A1 15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742795A1 Immuno-stimulatory monoclonal antibodies
11/20/1996EP0742794A1 Interleukin-6 (il-6) antagonists
11/20/1996EP0742721A1 Methods of prolonged suppression of humoral immunity
11/20/1996EP0627009B1 Macrocyclic lactones and a productive strain thereof
11/20/1996EP0550544B1 Antigen-antibody conjugates
11/20/1996CN1136314A Isoxazoline compounds as antiinflammatory agents
11/20/1996CN1136311A Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action
11/20/1996CN1135900A Ledebouriella polysaccharide and its preparation
11/20/1996CN1033325C Preparation of antiinflammatory hydroxamic acids and N-hydroxyureas
11/19/1996US5576438 Lipoxygenase inhibitors; antiallergens, antiinflammatory agents
11/19/1996US5576325 Pyrrolyl-4h-pyranoquinolines
11/19/1996US5576322 Anti-ischemic 2,4-diaminoquinazolines
11/19/1996US5576309 Estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition
11/19/1996US5576289 Methods for treating motor deficits
11/19/1996CA2111460C Tetrahydrobenzazepine derivatives which inhibit lipoxygenase
11/19/1996CA2109613C Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
11/19/1996CA2106200C Stereoselective preparation of substituted piperidines
11/19/1996CA1338728C Cyclosporins and their use a pharmaceuticals
11/14/1996WO1996035782A1 Il-6 activity inhibitor
11/14/1996WO1996035719A1 Transeptithelial transport of molecular species
11/14/1996WO1996035714A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035711A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
11/14/1996WO1996035687A1 Peptidyl compounds and their therapeutic use
11/14/1996WO1996035677A1 Nitric oxide synthase inhibitors derived from cyclic amidines
11/14/1996WO1996035667A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
11/14/1996WO1996035467A1 Coarse spray delivery of functional biologic materials
11/14/1996WO1996035443A1 Treatment for inhibiting the progression of autoimmune disease
11/14/1996WO1996022068A3 Methods and pharmaceutical compositions employing desmethylselegiline
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2219973A1 Peptidyl compounds and their therapeutic use
11/14/1996CA2219877A1 Treatment for inhibiting the progression of autoimmune disease
11/14/1996CA2218879A1 Coarse spray delivery of functional biologic materials
11/14/1996CA2218360A1 Nitric oxide synthase inhibitors derived from cyclic amidines
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996CA2217857A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
11/14/1996CA2217850A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
11/14/1996CA2216877A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
11/13/1996EP0742229A2 Induction of protection against viral infection
11/13/1996EP0742215A1 Cillianon, antibiotic from penicillin spe., and chemical derivatives thereof, method for their preparation and application
11/13/1996EP0742203A2 Vitamin D compounds and method of preparing these compounds
11/13/1996EP0742014A1 MHC-peptide labelled conjugates
11/13/1996EP0741788A1 Inducing tolerance with tolerogenic fusion proteins
11/13/1996EP0741784A1 Ligand (act-4-l) to a receptor on the surface of activated cd4?+ t-cells
11/13/1996EP0741783A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins
11/13/1996EP0741719A1 Intermediate and process for making
11/13/1996EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
11/13/1996EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents
11/13/1996EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
11/13/1996EP0741686A1 New leukotriene b 4? derivatives, methods of preparing them and their use as drugs
11/13/1996EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy
11/13/1996EP0741575A1 Human therapeutic uses of bpi protein products
11/13/1996EP0741573A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents
11/13/1996EP0474691B1 Monoclonal antibodies for inducing tolerance
11/13/1996EP0434744B1 Serum immunoregulatory polypeptide and uses therefor
11/13/1996CN1135718A Method and products for controlling immune responses in mammals
1 ... 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 ... 1172